- Home
- IOBT
IOBT
IO Biotech Inc.
as 11-25-2025 2:36pm EST
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
| Founded: | 2014 | Country: | Denmark |
| Employees: | 78 | City: | COPENHAGEN |
| Market Cap: | 57.2M | IPO Year: | 2021 |
| Target Price: | $3.50 | AVG Volume (30 days): | 993.9K |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.34 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.32 - $2.79 | Next Earning Date: | 11-14-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest IO Biotech Inc. News
IOBT Breaking Stock News: Dive into IOBT Ticker-Specific Updates for Smart Investing
Zacks
6 days ago
IO Biotech, Inc. (IOBT) Upgraded to Buy: Here's Why
GlobeNewswire
11 days ago
IO Biotech Reports Third Quarter 2025 Financial Results and Provides Business Highlights
GlobeNewswire
13 days ago
IO Biotech Announces Participation in Upcoming Investor Conferences
GlobeNewswire
18 days ago
IO Biotech Presents Pre-Clinical Data Highlighting the Potential of Additional Therapeutic Cancer Vaccine Candidates at the 2025 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
MT Newswires
6 months ago
IO Biotech Regains Compliance With Nasdaq Listing Rules
Zacks
6 months ago
IO Biotech, Inc. (IOBT) Just Flashed Golden Cross Signal: Do You Buy?
GlobeNewswire
6 months ago
IO Biotech Announces Participation in Cowen 6th Annual Oncology Innovation Summit and Jefferies Global Healthcare Conference
TipRanks
6 months ago
IO Biotech price target raised to $14 from $12 at H.C. Wainwright
Compare IOBT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IOBT IO Biotech Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.